With their triumphant advance, biosimilars are also setting in motion the usual market mechanisms. Biopharma interest groups warn against the automatic substitution of...
In this interview, Christene Smith sits down with Anne Lamp, the CEO & Co-Founder of Traceless Materials, to delve into the groundbreaking world of natural biopolymer...
CDMO CordenPharma, a specialist in active pharmaceutical ingredients (APIs), excipients, drug products and packaging services, inaugurated an increased commercial peptide...
The US Federal Trade Commission (FTC) wants to clear the takeover of Irish biotech company Horizon Therapeutics by pharmaceutical group Amgen. Following concessions by...
Cellares, a US-based integrated development and manufacturing organization (IDMO), has secured $255 million in Series C funding to establish a cell therapy development...
Fluor has been awarded a €444 million ($487 million) biotech expansion project in Denmark and is in the first phase of a new life sciences production facility in the US...
Japan-based specialty chemicals manufacturer Toyo Ink has signed an agreement to invest in US-based biotech company VLP Therapeutics (VLPT) and its subsidiary company VLP...
Alexion, AstraZeneca's rare disease division, has agreed to buy a portfolio of preclinical gene therapy programs and enabling technologies from competitor Pfizer for up...
